Related Experiment Video
Updated: Aug 1, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hyperglycemia and prematurity: a narrative review
Dimitrios Angelis1, Mambarambath A Jaleel2, Luc P Brion2
1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, TX, USA. dimitrios.angelis@utsouthwestern.edu.
Insights
Hyperglycemia (high blood sugar) is common in extremely preterm newborns due to immature metabolism. While linked to adverse outcomes, causality and optimal treatment for this condition remain unclear.
Area of Science:
- Neonatalogy
- Endocrinology
- Biochemistry
Background:
- Hyperglycemia is frequently observed in extremely preterm infants.
- Physiological causes include immaturity of glucose metabolism pathways.
- Existing research lacks definitive evidence for causality between hyperglycemia and adverse outcomes.
Purpose of the Study:
- To review the relationship between hyperglycemia and organ development in preterm newborns.
- To explore the association between hyperglycemia and immediate/long-term outcomes.
- To discuss current treatment options and identify knowledge gaps.
Main Methods:
- Literature review of studies on hyperglycemia in extremely preterm newborns.
- Analysis of data on organ development and clinical outcomes.
- Synthesis of information on treatment strategies and research needs.
Main Results:
- Hyperglycemia is common and less understood than hypoglycemia in this population.
- Immature cellular pathways contribute to glucose dysregulation.
- Observed associations with adverse outcomes require further investigation for causality.
Conclusions:
- Understanding hyperglycemia in preterm infants is complicated by varying definitions and treatments.
- Further research is needed to establish causality and optimize management.
- Clarifying the impact of hyperglycemia on development and outcomes is crucial.
Abstract:
Hyperglycemia is commonly encountered in extremely preterm newborns and physiologically can be attributed to immaturity in several biochemical pathways related to glucose metabolism. Although hyperglycemia is associated with a variety of adverse outcomes frequently described in this population, evidence for causality is lacking. Variations in definitions and treatment approaches have further complicated the understanding and implications of hyperglycemia on the immediate and long-term effects in preterm newborns. In this review, we describe the relationship between hyperglycemia and organ development, outcomes, treatment options, and potential gaps in knowledge that need further research. IMPACT: Hyperglycemia is common and less well described than hypoglycemia in extremely preterm newborns. Hyperglycemia can be attributed to immaturity in several cellular pathways involved in glucose metabolism in this age group. Hyperglycemia has been shown to be associated with a variety of adverse outcomes frequently described in this population; however, evidence for causality is lacking. Variations in definitions and treatment approaches have complicated the understanding and the implications of hyperglycemia on the immediate and long-term effects outcomes. This review describes the relationship between hyperglycemia and organ development, outcomes, treatment options, and potential gaps in knowledge that need further research.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational
Hypoglycemia and Glucagon
SBAR II: Application of SBAR
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Symptoms, Diagnosis, and Complications